Xtacy Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TT5?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,852,62110.1%
General Public52,304,35089.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.2%.


Top Shareholders

Top 3 shareholders own 10.06% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.89%
Meris Kott
5,752,621€95.3k0%no data
0.086%
Ashleigh Vogstad
50,000€828.20%no data
0.086%
Lindsey Perry
50,000€828.20%no data